These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 27812511)

  • 1. Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison.
    Pais P; Costa C; Cavalheiro M; Romão D; Teixeira MC
    Front Cell Infect Microbiol; 2016; 6():131. PubMed ID: 27812511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of multidrug resistance in pathogenic fungi.
    Morschhäuser J
    Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Mediator in virulence and antifungal drug resistance in pathogenic fungi.
    Moran GP; Anderson MZ; Myers LC; Sullivan DJ
    Curr Genet; 2019 Jun; 65(3):621-630. PubMed ID: 30637479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogen regulation of virulence in clinically prevalent fungal pathogens.
    Lee IR; Morrow CA; Fraser JA
    FEMS Microbiol Lett; 2013 Aug; 345(2):77-84. PubMed ID: 23701678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH signaling in human fungal pathogens: a new target for antifungal strategies.
    Cornet M; Gaillardin C
    Eukaryot Cell; 2014 Mar; 13(3):342-52. PubMed ID: 24442891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.
    Thammahong A; Puttikamonkul S; Perfect JR; Brennan RG; Cramer RA
    Microbiol Mol Biol Rev; 2017 Jun; 81(2):. PubMed ID: 28298477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus.
    Karkowska-Kuleta J; Rapala-Kozik M; Kozik A
    Acta Biochim Pol; 2009; 56(2):211-24. PubMed ID: 19543556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistance.
    Paul S; Doering TL; Moye-Rowley WS
    Fungal Genet Biol; 2015 Jan; 74():1-9. PubMed ID: 25445311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated regulation of iron metabolism in Cryptococcus neoformans by GATA and CCAAT transcription factors: connections with virulence.
    Jung WH; Sánchez-León E; Kronstad JW
    Curr Genet; 2021 Aug; 67(4):583-593. PubMed ID: 33760942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidative stress response of the opportunistic fungal pathogen Candida glabrata.
    Briones-Martin-Del-Campo M; Orta-Zavalza E; Juarez-Cepeda J; Gutierrez-Escobedo G; Cañas-Villamar I; Castaño I; De Las Peñas A
    Rev Iberoam Micol; 2014; 31(1):67-71. PubMed ID: 24270068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory circuitry governing fungal development, drug resistance, and disease.
    Shapiro RS; Robbins N; Cowen LE
    Microbiol Mol Biol Rev; 2011 Jun; 75(2):213-67. PubMed ID: 21646428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90-dependent regulatory circuitry controlling temperature-dependent fungal development and virulence.
    O'Meara TR; Cowen LE
    Cell Microbiol; 2014 Apr; 16(4):473-81. PubMed ID: 24438186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Strategies of Pathogenic
    Kämmer P; McNamara S; Wolf T; Conrad T; Allert S; Gerwien F; Hünniger K; Kurzai O; Guthke R; Hube B; Linde J; Brunke S
    mBio; 2020 Oct; 11(5):. PubMed ID: 33024045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights in pathogenic fungal biofilms.
    Sardi Jde C; Pitangui Nde S; Rodríguez-Arellanes G; Taylor ML; Fusco-Almeida AM; Mendes-Giannini MJ
    Rev Iberoam Micol; 2014; 31(1):22-9. PubMed ID: 24252828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi.
    Ries LNA; Beattie S; Cramer RA; Goldman GH
    Mol Microbiol; 2018 Feb; 107(3):277-297. PubMed ID: 29197127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA; Messer SA; Jones RN; Castanheira M
    J Antibiot (Tokyo); 2015 Sep; 68(9):556-61. PubMed ID: 25899126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.